Are immunosuppressive conditions and preoperative corticosteroid treatment risk factors in inguinal hernia repair?
Complication
Corticosteroid treatment
Immunosuppression
Inguinal hernia
Seroma
Surgical side infection
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
14
02
2020
accepted:
11
06
2020
pubmed:
20
6
2020
medline:
30
9
2021
entrez:
20
6
2020
Statut:
ppublish
Résumé
Immunosuppressive conditions and/or preoperative corticosteroid treatment have a negative influence on wound healing and can, therefore, lead to higher rates of surgical site infections (SSIs) and seromas. For inguinal hernia, no such studies have been carried out to date. In an analysis of data from the Herniamed Registry, 2312 of 142,488 (1.6%) patients with primary unilateral inguinal hernia repair had an anamnestic history of an immunosuppressive condition and/or preoperative corticosteroid treatment. Using propensity score matching, 2297 (99.4%) pairs with comparative patient characteristics were formed. These were then compared using the following primary outcome criteria: intra- and postoperative complications, complication-related reoperations, recurrence at one-year follow-up, pain on exertion, pain at rest, and chronic pain requiring treatment at one-year follow-up. Of the 2297 matched pairs with primary unilateral inguinal hernia repair, 82.76% were male patients. 1010 (44.0%) were operated in laparo-endoscopic techniques (TEP, TAPP), 1225 (53.3%) in open techniques (Bassini, Shouldice, Lichtenstein, Plug, TIP, Gilbert, Desarda), and 62 (2.7%) in other techniques. The matched pair analysis results did not identify any disadvantage in terms of the outcome criteria for patients with an anamnestic history of immunosuppressive condition and/or preoperative corticosteroid treatment (yes vs no). In particular, no disadvantage was noted in the rate of surgical site infections (0.65% vs 0.70%; ns) or seromas (1.22% vs 1.57%; ns). The overall rates of postoperative complications were 3.40% vs 4.31% (p = ns) (plus 0.22% concordant events in five matched pairs). In primary unilateral inguinal hernia surgery, an immunosuppressive condition and/or preoperative corticosteroid treatment does not appear to have a negative influence on wound complications.
Identifiants
pubmed: 32556698
doi: 10.1007/s00464-020-07736-9
pii: 10.1007/s00464-020-07736-9
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2953-2964Références
Kingsnorth A, LeBlanc K (2003) Hernias: inguinal and incisional. Lancet 362(9395):1561–1571
doi: 10.1016/S0140-6736(03)14746-0
pubmed: 14615114
The HerniaSurge Group (2018) International guidelines for groin hernia management. Hernia 22:1–165. https://doi.org/10.1007/s10029-017-16668-x
doi: 10.1007/s10029-017-16668-x
Simons MP, Aufenacker T, Bay-Nielsen M, Bouillot JL, Campanelli G, Conze J, de Lange D, Fortelny R, Heikkinen T, Kingsnorth A, Kukleta J, Morales-Conde S, Nordin P, Schumpelick V, Smedberg S, Smietanski M, Weber G, Miserez M (2009) European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia 13:343–403. https://doi.org/10.1007/s10029-009-0529-7
doi: 10.1007/s10029-009-0529-7
pubmed: 19636493
pmcid: 2719730
Bittner R, Arregui ME, Bisgaard T, Dudai M, Ferzli GS, Fitzgibbons RJ, Fortelny RH, Klinge U, Köckerling F, Kuhry E, Kukleta J, Lomanto D, Misra MC, Montgomery A, Morales-Conde RW, Rosenberg J, Sauerland S, Schug-Pass C, Singh K et al (2011) Guidelines for laparoscopic (TAPP) and endoscopic (TEP) treatment of inguinal hernia [International Endohernia Society (IEHS)]. Surg Endosc 25:2773–2843. https://doi.org/10.1007/s00464-011-1799-6
doi: 10.1007/s00464-011-1799-6
pubmed: 21751060
pmcid: 3160575
Bittner R, Montgomery MA, Arregui E, Bansal V, Bingener J, Bisgaard T, Buhck H, Dudai M, Ferzli GS, Fitzgibbons RJ, Fortelny RH, Grimes KL, Klinge U, Köckerling F, Kumar S, Kukleta J, Lomanto D, Misra MC, Morales-Conde S, Reinpold W, Rosenberg J, Singh K, Timoney M, Weyhe D, Chowbey P (2015) Update of guidelines on laparoscopic (TAPP) and endoscopic (TEP) treatment of inguinal hernia (International Endohernia Society). Surg Endosc 29:289–321. https://doi.org/10.1007/s00464-014-3917-8
doi: 10.1007/s00464-014-3917-8
pubmed: 25398194
Miserez M, Peeters E, Aufenacker T, Bouillot JL, Campanelli G, Conze J, Fortelny R, Heikkinen T, Jorgensen LN, Kukleta J, Morales-Conde S, Nordin P, Schumpelick V, Smedberg S, Smietanski M, Weber G, Simons MP (2014) Update with level 1 studies of the European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia 18:151–163. https://doi.org/10.1007/s10029-014-1236-6
doi: 10.1007/s10029-014-1236-6
pubmed: 24647885
Weyhe D, Navid T, Sahlmann B, Uslar VN (2017) Risk factors for perioperative complications in inguinal hernia repair: a systematic review. Innov Surg Sci 2:47–52. https://doi.org/10.1515/iss-2017-0008
doi: 10.1515/iss-2017-0008
pubmed: 31579736
pmcid: 6754002
Köckerling F et al (2019) Comparing routine administrative data with registry data for assessing quality of hospital care in patients with inguinal hernia. Hernia. https://doi.org/10.1007/s10029-019-02009-4
doi: 10.1007/s10029-019-02009-4
pubmed: 31786700
pmcid: 7395912
Esposito S (2001) Immune system and surgical site infection. J Chemother 13(1):12–16. https://doi.org/10.1179/joc.2001.13.Supplement-2.12
doi: 10.1179/joc.2001.13.Supplement-2.12
pubmed: 11936355
Avishai E, Yeghiazaryan K, Golubnitschaja O (2017) Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalized medicine. EPMA J 8:23–33. https://doi.org/10.1007/s13167-017-0081-y
doi: 10.1007/s13167-017-0081-y
pubmed: 28620441
pmcid: 5471802
Ranson WA, White SJW, Cheung ZB, Mihail C, YeI KJS, Cho SK (2018) The effects of chronic preoperative streroid therapy on perioperative complications following elective posterior lumbar fusion. Glob Spine J 8:834–841. https://doi.org/10.1177/2192568218775960
doi: 10.1177/2192568218775960
Arbid SA, El-Khoury H, Faek J, Tamim H, Chami H (2019) Association of preoperative systematic corticosteroid therapy with surgical outcomes in chronic obstructive pulmonary disease patients. Ann Thorac Med 14:141–147. https://doi.org/10.4103/atm.ATM_245_18:10.4103/atm.ATM_245_18
doi: 10.4103/atm.ATM_245_18:10.4103/atm.ATM_245_18
pubmed: 31007766
pmcid: 6467015
Ismael H, Horst M, Farooq M, Jordon J, Patton JH, Rubinfeld IS (2011) Adverse effects of preoperative steroid use on surgical outcomes. Am J Surg 201(305–8):308–309. https://doi.org/10.1016/j.amjsurg.2010.09.018
doi: 10.1016/j.amjsurg.2010.09.018
Wang AS, Armstrong EJ, Armstrong AW (2013) Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg 206:410–417. https://doi.org/10.1016/j.amjsurg.2012.11.018
doi: 10.1016/j.amjsurg.2012.11.018
pubmed: 23759697
Mazzei M, Zhao H, Edwards MA (2019) Perioperative outcomes of bariatric surgery in the setting of chronic steroid use: an MBSAQIP database analysis. Surg Obes Relat Dis 15:926–934. https://doi.org/10.1016/j.soard.2019.02.007
doi: 10.1016/j.soard.2019.02.007
pubmed: 31101563
Bootun R (2013) Effects of immunosuppressive therapy on wound healing. Int Wound J 10:98–104. https://doi.org/10.1111/j.1742-481X.2012.00950.x
doi: 10.1111/j.1742-481X.2012.00950.x
pubmed: 22364410
Nguyen GC, Elnahas A, Jackson TD (2014) The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease. J Crohn’s Colit 8:1661–1667. https://doi.org/10.1016/j.crohns.2014.07.007
doi: 10.1016/j.crohns.2014.07.007
Haskins IN, Krpata DM, Prabu AS, Tastaldi L, Perez AJ, Tu C, Rosenblatt S, Poulose BK (2018) Immunosuppression is not a risk factor for 30-day wound events or additional 30-day morbidity or mortality after open ventral hernia repair: An analysis of the Americas Hernia Society Quality Collaborative. Surgery 164:594–600. https://doi.org/10.1016/j.surg.2018.05.023
doi: 10.1016/j.surg.2018.05.023
pubmed: 30029991
Stechemesser B, Jacob DA, Schug-Pass C, Köckerling F (2012) Herniamed: an internet-based registry for outcome research in hernia surgery. Hernia 16:269–276. https://doi.org/10.1007/s10029-012-0908.3
doi: 10.1007/s10029-012-0908.3
pubmed: 22389073
Kyle-Leinhase I, Köckerling F, Jorgensen LN, Montgomery A, Gillion JF, Rodriguez JAP, Hope W, Muysoms F (2018) Comparison of hernia registries: the CORE project. Hernia 22:561–575. https://doi.org/10.1007/s10029-017-1724-6
doi: 10.1007/s10029-017-1724-6
pubmed: 29307057
pmcid: 6061062
Köckerling F, Bittner R, Kofler M, Mayer F, Adolf D, Kuthe A, Weyhe D (2019) Lichtenstein versus total extraperitoneal patch plasty versus transabdominal patch plasty technique for primary unilateral inguinal hernia repair. Ann Surg 269:351–357
doi: 10.1097/SLA.0000000000002541
pubmed: 28953552
Haapaniemi S, Nilsson E (2002) Recurrence and pain three years after groin hernia repair. Validation of postal questionnaire and selective physical examination as a method of follow-up. Eur J Surg 168:22–28. https://doi.org/10.1080/110241502317307535
doi: 10.1080/110241502317307535
pubmed: 12022367
Miserez M, Alexandre JH, Campanelli G, Corcione F, Cuccurullo D, Pascual MH, Hoeferlin A, Kongsnorth AN, Mandala V, Palot JP, Schumpelick V, Simmermacher RK, Stoppa R, Flament JB (2007) The European hernia society groin hernia classification: simple and easy to remember. Hernia 11:113–116
doi: 10.1007/s10029-007-0198-3
pubmed: 17353992
Harpaz R, Dahl RM, Dooling KL (2016) Prevalence of immunosuppression among US Adults, 2013. JAMA 316:23
doi: 10.1001/jama.2016.16477